FDA Backs Nerve Drug for Pain
Tapentadol (Nucynta ER), a long-acting oral opioid, is now approved by the Food and Drug Administration for treating pain stemming from diabetic peripheral neuropathy. This condition is associated with the deterioration of nerves, which may lead to tingling, a loss of sensation, or pain in the arms, legs, hands, and feet. Tapentadol is intended for those with chronic pain, who require around-the-clock relief, and is taken twice a day. As an opioid, tapentadol can be habit forming. The most common side effects are nausea, dizziness, vomiting, drowsiness, and headache.